What is the recommended polymyxin B loading dose for adults and children with normal or moderately impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polymyxin B Loading Dose

For adults and children with normal or moderately impaired renal function, administer a loading dose of 2–2.5 mg/kg of polymyxin B, regardless of renal status. 1

Rationale for Loading Dose

The loading dose is critical because polymyxin B has a relatively long half-life and requires time to reach steady-state plasma concentrations. Without a loading dose, patients experience suboptimal drug levels for the first 2-3 days of therapy, which is associated with higher mortality in critically ill patients 1. The loading dose should be administered to ALL patients, including those with renal dysfunction, because polymyxin B clearance is not significantly influenced by renal function 1.

Dosing Algorithm

Adults:

  • Loading dose: 2–2.5 mg/kg (typically 150-200 mg for a 70 kg patient)
  • Maintenance dose: 1.5–3 mg/kg/day divided in 2 doses (every 12 hours)
  • Key point: The same loading dose applies regardless of renal function 1

Children:

  • The guideline evidence provides the same weight-based loading dose of 2–2.5 mg/kg 1
  • FDA labeling indicates infants with normal kidney function may receive up to 40,000 units/kg/day (approximately 4 mg/kg/day) without adverse effects 2

Critical Implementation Points

Renal function considerations:

  • Unlike colistin, polymyxin B plasma concentrations are NOT influenced by renal function 1
  • No dose adjustment is necessary for the loading dose in renal impairment 1
  • For patients on continuous renal replacement therapy (CRRT), use the same loading dose with no adjustment required 1

Maintenance dosing after loading:

  • Patients with normal renal function: 1.5–3 mg/kg/day in 2 divided doses 1
  • Patients on CRRT: Same maintenance dose as normal renal function (no adjustment needed) 1
  • Recent research suggests fixed maintenance dosing (75-100 mg every 12 hours) may optimize the safety-efficacy balance in patients weighing 50-90 kg 3, 4

Common Pitfalls to Avoid

  1. Do not skip the loading dose in renal impairment – This is a critical error. The loading dose achieves optimal plasma levels on day 1, which is essential for mortality reduction 1

  2. Do not confuse polymyxin B with colistin dosing – Colistin is administered as an inactive prodrug (colistimethate sodium) with different pharmacokinetics. Polymyxin B is given as the active drug and dosed by body weight 1

  3. Avoid nephrotoxic drug combinations – Do not combine with aminoglycosides or other nephrotoxic agents when possible, as polymyxin B carries inherent nephrotoxicity risk 5

  4. Monitor renal function closely – Despite not requiring dose adjustment for renal impairment, therapeutic drug monitoring (TDM) is encouraged where available to optimize efficacy and minimize toxicity 5, 6

Dosing Unit Clarification

Polymyxin B sulfate: 1 mg = 10,000 units 5, 2

Therefore, a 2.5 mg/kg loading dose for a 70 kg patient = 175 mg = 1,750,000 units

Related Questions

What is the recommended loading and maintenance dosing regimen for polymyxin B?
What is the recommended dosage of Polymyxin B for adults and children, including adjustments for renal impairment?
What are the pharmacokinetic properties of Polymyxin B, including its route of administration, distribution volume, protein binding, metabolism, clearance, half‑life, and dosing adjustments in renal impairment?
How should the dose of Polymyxin B be adjusted in patients with impaired renal function?
What is the appropriate polymyxin B dose in international units for a 70‑kg adult with a creatinine clearance of 20–30 mL/min, including loading and maintenance dosing?
In a female patient with severe pain and likely renal impairment from peritoneal disease, should we switch her from morphine to a fentanyl-based regimen given that fentanyl is metabolized in the liver while morphine relies on renal clearance?
How should I assess capacity and conduct a psychiatric evaluation for an elderly female patient being considered for spinal cord stimulator implantation?
What is the recommended loading and maintenance dosing regimen for polymyxin B?
In an HIV‑positive patient on highly active antiretroviral therapy (HAART) with a CD4 count of 195 cells/µL, elevated serum β‑D‑glucan, a two‑week history of cough, fever, and dyspnea, clear lung auscultation, sputum gram stain showing neutrophils and mixed oral flora, negative methenamine‑silver stain, and chest CT demonstrating bilateral upper‑lobe‑predominant patchy ground‑glass opacities without pleural effusion or nodules, what is the most likely diagnosis?
What information should a patient know to safely manage care in the anesthesia recovery area (post‑anesthesia care unit)?
What treatments are recommended for a patient with a coronary calcium score of 335?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.